Illinois House Resolution 158 calls for an investigation into the 340B Drug Pricing Program's use in Illinois.
Illinois House Resolution 158 directs the Auditor General to investigate the 340B Drug Pricing Program's use by covered entities within Illinois. The investigation will assess profits, spending on third-party administrators, drug title maintenance, markups, and discount passing to vulnerable patients. It will also examine the program's impact on state health programs like Medicaid and the State Employees Group Insurance Program, aiming to improve transparency and accountability. The resolution emphasizes the importance of ensuring the program's benefits reach vulnerable patient populations.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.